Benzinga | May 14, 2021 08:54AM EDT

Kintara Therapeutics Q3 EPS $(0.23) Down From $(0.17) YoY

Kintara Therapeutics (NASDAQ:KTRA) reported quarterly losses of $(0.23) per share. This is a 35.29 percent decrease over losses of $(0.17) per share from the same period last year.